VSPharmTech
PrivateLast Round
Series C
Jun 1, 2026
Est. Valuation
$68.9M
Total Funding Raised
$14.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
VSPharmTech is a biotechnology company that develops innovative radiosensitizer drugs designed to enhance the effectiveness of radiation therapy for various types of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VSPharmTech Comparables
Compare VSPharmTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. | 85% | |
| KORTUC INC. | 80% | |
| DNA Therapeutics | 79% | |
VSPharmTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 1, 2026 | ||||
| Series B Extension | Sep 18, 2025 | ||||
| Series B | Oct 1, 2023 | ||||
| VC Round | Apr 11, 2023 | ||||
| Series A | Apr 8, 2022 | ||||
Seed | May 18, 2020 |
VSPharmTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y&Archer | Seed, Accelerator |
| SL Investment | Series B |
| IBK Capital | Series B |
| Kairos Ventures | VC Round |
| Korea Development Bank | Series B |
| ST Capital (Korea) | Series A |
| Enlight Ventures | Seed, Series B, VC Round, Series A, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 167% MoM, reaching 650.
- Jun 1, 2026
$40M round completed.
VSPharmTech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VSPharmTech's valuation, stock price, and market status.